A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and α2-adrenergic receptors on morbidity and mortality in patients with heart failure-Reference-Cited by-同舟云学术

A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and α2-adrenergic receptors on morbidity and mortality in patients with heart failure

Published:2008-01 Issue:1 Volume:10 Page:89-95
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Torp-Pedersen Christian¹,Køber Lars²,Carlsen Jan E.³,Akkan Dilek⁴,Bruun Niels E.⁴,Dacoronias Dimitri⁵,Dickstein Kenneth⁶,Haghfelt Torben⁷,Öhlin Hans⁸,McMurray John JV⁹

Affiliation:

1. Dept. Cardiology; Bispebjerg University Hospital, Bispebjerg Bakke; 2400 Copenhagen NV Denmark

2. Department of Cardiology; The National Hospital; Copenhagen Denmark

3. Cyncron A/S; Copenhagen Denmark

4. Department of Cardiology; Gentofte University Hospital; Copenhagen Denmark

5. Corporate Medical Department, Chiesi Farmaceutici S.p.A. Parma; Italy

6. Cardiology Division; University of Bergen, Stavanger University Hospital; Norway

7. Department of Cardiology; Odense University Hospital; Odense Denmark

8. Department of Cardiology; University Hospital; Lund Sweden

9. Department of Cardiology; Western Infirmary; Glasgow Scotland UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial;Poole-Wilson;Lancet,2003

2. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON);Cohn;Eur J Heart Fail,2003

3. Haemodynamic and neurohormones release inhibiting effects of a DA2/alpha2 agonist;Razzetti;Eur J. Heart Fail,2000

4. Reduction of sympathetic drive and collagen deposition with a DA2 agonist in an experimental model of left ventricular dysfunction after myocardial infarction;Latini;Eur J Heart Fail,1997

5. Hemodynamic effects of graded oral doses of a new dopaminergic analogue CHF 1035 in patients with congestive heart failure;Morisco;JACC,1995

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Death without Previous Hospital Readmission in Patients with Heart Failure with Reduced Ejection Fraction—A New Endpoint from Old Clinical Trials;Journal of Clinical Medicine;2022-09-21

2. Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology;Medical Review;2021-07-01

3. Recent updates on novel therapeutic targets of cardiovascular diseases;Molecular and Cellular Biochemistry;2020-08-26

4. Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure;The Pharmacogenomics Journal;2019-01-17

5. Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides;ESC Heart Failure;2018-03-09